Paper728348
Cell yield and cell survival following chemotherapy of the B16 melanoma.
Stephens TC and 1 other. Br J Cancer, 1978. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Cell yield and cell survival following chemotherapy of the B16 melanoma. Papers, record 728348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/728348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| Alkylating Agents | |
| Animals | |
| Cell Count | |
| Cell Survival | |
| Female | |
| Mice | |
| Neoplasms, Experimental | |
| Vinca Alkaloids |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 921888 | Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. | Br J Cancer | 1977 | https://conductscience.org/library/papers/921888 | PubMed |
| 3 | 889685 | Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. | Br J Cancer | 1977 | https://conductscience.org/library/papers/889685 | PubMed |
| 4 | 5874788 | A cell dispersion technique for use in quantitative transplantation studies with solid tumours. | Eur J Cancer (1965) | 1965 | https://conductscience.org/library/papers/5874788 | PubMed |
| 5 | 953998 | In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. | Cancer Res | 1976 | https://conductscience.org/library/papers/953998 | PubMed |
| 6 | 5417507 | Giant histiocytes after cyclophosphamide. | Experientia | 1970 | https://conductscience.org/library/papers/5417507 | PubMed |
| 7 | 4981449 | Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV x-rays. I. Effects of single exposures. | Eur J Cancer (1965) | 1969 | https://conductscience.org/library/papers/4981449 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24329803 | Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy. | Immunol Rev | 2014 | https://conductscience.org/library/papers/24329803 | PubMed |
| 22124930 | A microfluidic system for investigation of extravascular transport and cellular uptake of drugs in tumors. | Biotechnol Bioeng | 2012 | https://conductscience.org/library/papers/22124930 | PubMed |
| 20065066 | CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. | J Exp Med | 2010 | https://conductscience.org/library/papers/20065066 | PubMed |
| 7236488 | Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7236488 | PubMed |
| 7059461 | Response of two mouse tumours to hyperthermia with CCNU or melphalan. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7059461 | PubMed |
| 7000124 | Experimental chemotherapy studies: intercomparison of assays. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000124 | PubMed |
| 7000122 | Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000122 | PubMed |
| 6932930 | An appraisal of in vivo assays of excised tumours. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/6932930 | PubMed |
| 6896455 | Clonal variation in the sensitivity of B16 melanoma to m-AMSA. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6896455 | PubMed |
| 6743517 | Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6743517 | PubMed |
| 6731586 | Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation. | Am J Pathol | 1984 | https://conductscience.org/library/papers/6731586 | PubMed |
| 6191768 | The effect of lithium chloride on tumour appearance and survival of melanoma-bearing mice. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6191768 | PubMed |
| 3954945 | Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3954945 | PubMed |
| 2292139 | Vascular attack as a therapeutic strategy for cancer. | Cancer Metastasis Rev | 1990 | https://conductscience.org/library/papers/2292139 | PubMed |
| 1432039 | Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model. | J Neurooncol | 1992 | https://conductscience.org/library/papers/1432039 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/728348
GET https://conductscience.org/api/papers/v1/728348/authors